MENU
+Compare
LFSC
ETF ticker: NASDAQ
AS OF
Aug 8 closing price
Price
$25.27
Change
+$0.29 (+1.16%)

LFSC stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Health
LFSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for LFSC with price predictions
Aug 08, 2025

LFSC's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for LFSC turned positive on August 08, 2025. Looking at past instances where LFSC's MACD turned positive, the stock continued to rise in of 4 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 7 cases where LFSC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 07, 2025. You may want to consider a long position or call options on LFSC as a result. In of 11 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

LFSC moved above its 50-day moving average on August 07, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LFSC advanced for three days, in of 36 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LFSC moved out of overbought territory on July 15, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 2 similar instances where the indicator moved out of overbought territory. In of the 2 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The 10-day moving average for LFSC crossed bearishly below the 50-day moving average on August 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 1 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFSC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LFSC broke above its upper Bollinger Band on August 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for LFSC entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Guardant Health (NASDAQ:GH), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund’s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

Market Cap

The average market capitalization across the F/m Emerald Life Sciences Innovation ETF ETF is 4.24B. The market cap for tickers in the group ranges from 456.29M to 23.16B. INSM holds the highest valuation in this group at 23.16B. The lowest valued company is SVRA at 456.29M.

High and low price notable news

The average weekly price growth across all stocks in the F/m Emerald Life Sciences Innovation ETF ETF was 4%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was -2%. GH experienced the highest price growth at 31%, while SYRE experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the F/m Emerald Life Sciences Innovation ETF ETF was -16%. For the same stocks of the ETF, the average monthly volume growth was 11% and the average quarterly volume growth was 60%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 69
P/E Growth Rating: 77
Price Growth Rating: 58
SMR Rating: 87
Profit Risk Rating: 75
Seasonality Score: -13 (-100 ... +100)
View a ticker or compare two or three
LFSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details